Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anyone else getting tired of the iHub spam? I'm getting tired of closing windows to return to iHub... if they're not careful they're just going to drive people away from the site and to other sites that don't do that...
Wow... that would be awesome... I didn't realize that international companies attend there... hopefully we get some news about the EU soon... the German web site has been up for awhile now...
Chickchat was posted here first by our friend chances over a week ago... excellent research chances... thanks for sharing!
Excellent... I'll try to stop by a Walgreens in my area and see how it looks there...
News - O24 Fibromyalgia Featured on National Television Show 'Walgreens Health Corner'
Business Wire - March 01, 2006 08:49
TORONTO, Mar 01, 2006 (BUSINESS WIRE) -- Swiss Medica, Inc. (OTCBB:SWME) is pleased to announce that O24 Fibromyalgia was recently prominently featured on a segment on Fibromyalgia that aired on the "Walgreens Heath Corner" TV show that airs every Sunday morning on the Lifetime Network across the United States. Lifetime Network is one the highest rated cable television networks in the United States.
Lynne Matallana, President of the National Fibromyalgia Association (NFA), was interviewed on Health Corner TV and O24 Fibromyalgia was highlighted as the first and only product to receive the NFA Seal of Approval.
To view the clip on Fibromyalgia, please visit:
http://www.024zone.com/healthcorner
Swiss Medica's President Grant Johnson noted, "As the first clinically tested OTC product for Fibromyalgia available in pharmacies in North America, O24 Fibromyalgia is receiving rave reviews from both consumers and the medical community as a safe, quick and effective pain reliever for the pain symptoms related to Fibromyalgia."
The Fibromyalgia segment is expected to re-air on the Health Corner TV show.
O24 Fibromyalgia is available nationally in retailers in North America, including Rite Aid and Shoppers Drug Mart. Please visit www.O24zone.com for a store locator.
Swiss Medica Samples O24 Pain Neutralizer To One Million Seniors In USA
Business Wire - February 28, 2006 08:00
TORONTO, Feb 28, 2006 (BUSINESS WIRE) -- Swiss Medica, Inc. (OTCBB:SWME) is pleased to announce the launch of the first wave of its largest consumer sampling program to date, reaching 1 million seniors in late February/early March with information and a sample of O24 Pain Neutralizer. The first sampling program took part in senior publications in Boston, Chicago, Los Angeles, New York, Phoenix, and various markets in Florida.
"When we sampled seniors directly in the past, sales at retail in those markets increased dramatically over markets where we did not do direct sampling", said Wendy Kramer, Vice President of Swiss Medica. "We are very excited about this large national sampling program and plan on reaching millions of consumers and allied health professionals with product samples and information in 2006."
The towelette sample was attached to an informational postcard and inserted into senior newspapers that were either mailed to the consumer or available in their apartment or senior center.
O24 Pain Neutralizer is available nationally in retailers in North America, including CVS/Pharmacy, Walgreens, Rite Aid and Shoppers Drug Mart.
About Swiss Medica, Inc.
Swiss Medica commercializes clinically tested, patented natural products that relieve chronic ailments. We grow our brands through focused distribution and marketing strategies. Swiss Medica's mission is to be a world leader in the commercialization of safe, effective chronic ailment products that improve quality of lives. Please visit our websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com.
Swiss Medica's flagship product, the O24 Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24 pain relief solution has been used and recommended for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available over-the-counter throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.
Swiss Medica has recently launching the patented O24 Fibromyalgia pain reliever (US Patent #6,444,238B1) over-the-counter in North American retailers. The National Fibromyalgia Association (NFA) recently awarded O24 Fibromyalgia their first NFA Seal of Approval. Over 10 million Americans suffer from the long-term pain associated with Fibromyalgia. In a randomized double blind clinical trial conducted in 2005, 88 per cent of the patients who used O24 Fibromyalgia reported mild to markedly better improvement, versus only 7 per cent who used the placebo. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest retailer.
Swiss Medica also distributes PMS Escape(R) which holds US Patent #'s 5760014 and 5612320. PMS Escape(R) is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: www.pmsescape.com for additional information and ordering details.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to acceptance of Swiss Medica's products in Canada, the United States and other countries, risks related to international sales and purchases and potential foreign currency exchange fluctuations, acceptance of Swiss Medica's products, increased levels of competition, , dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
Swiss Medica, Inc. (OTC Bulletin Board:SWME)
SOURCE: Swiss Medica, Inc.
Swiss Medica, Inc.
Investor Relations Contact:
David Jones
(866) 485-4243
djones@swissmedica.com
OR
Fusion Communications
Media Contact:
Dean Mailey
(604) 218-6767
dean@fusioncom.ca
I agree... it should bear much fruit... I think the foundation is being laid now for very good things to come later this year... our day will come...
I stopped by an Ekards in Alpharetta today and did not see any O24 yet... I didn't have time to speak with the pharmacist or manager but it definitely was not there with the other topical pain relievers...
Great to hear that the product worked so well for your friend!
Haven't seen an Eckards this weekend but I should be able to stop by one tomorrow... D
Excellent... good targeted marketing... glad to hear it's on Radio as well... thanks for sharing... you're the man!
Strange day... incredibly low volume... I think this is the lowest volume in a year or two... no one wanted to buy or sell at this level today... chart looks good though and I'm encouraged that no one is stepping in to sell... we should bounce from here... looks like a cup and handle forming but we've failed the last few cup and handle patterns... I think this one will succeed for a change... if it does we're looking much higher prices within a few weeks...
http://stockcharts.com/def/servlet/SC.web?c=swme,uu[w,a]daclyyay[dc][pb13!b50][vc60][iUc20!Ll14]&....
I think it's coming too.. IMO we're worth .40-50 right now and $1 if they can get to 15+ million in revenue this year with profits in the next Q or two... I think it's very possible if not likely... we're clearly undervalued given all the progress that has been made in a international product launch...
Wow... that's great to know... thanks for the info!
Oh wow... I had no idea... so they are present at all the conventions then I guess... sweet!
Thanks chances! You're a wealth of information as always... thanks for sharing!
I couldn't agree more chances... definitely time to buy SWME on weakness now... I've also been watching MCU and thinking about getting in... I've also been watching VRTX an would like to get in that on a pullback... problem is I don't have enough money... a lot is tied up in SWME! could be worse I guess... :) GLTY!
Hell yea.. excellent news... I'll look in my local stores to see what the initial shipments look like... I'm not that concerned about the warrants and certainly not at this price... it will cause some dilution but not massive... as long as they get reasonable debt financing (which I hear they are) and don't print more shares, we should be fine...
Here we go! Strong opening... lots of bids stacked at .19... finally...
looking good! I think the reversal is in and the climb is on... time to buy the dips... added more today myself... still way underwater but looking up! GLTA longs!
thanks porsha! eom
no I sure don't chance... I'm wondering the same thing... I would have thought ben gay or icy hot
O24 Pain Neutralizer is 3rd Best Selling Topical Pain Reliever in Canada in 2005, Outselling Ben-Gay'TM', Tiger Balm'TM' And Icy Hot'TM'
Business Wire - January 30, 2006 08:00
TORONTO, Jan 30, 2006 (BUSINESS WIRE) -- Swiss Medica, Inc. (OTCBB:SWME) is pleased to announce that according to AC Nielson sales rankings for the 52-week period ending December 24, 2005, the 30ml spray bottle of O24 Pain Neutralizer was ranked the 3rd best selling product, out of 257 products, in the topical analgesic pain relief category in Canadian drugstores, based on dollar sales at the retail level. O24 Pain Neutralizer was nationally launched in Canadian drugstores in September 2004.
Swiss Medica's Chief Executive Officer, Raghu Kilambi noted "This is a very competitive market, where Canadian consumers have over 250 choices for topical pain relief products. The fact that O24 Pain Neutralizer outsold established brands such as Ben-Gay(TM), Tiger Balm(TM) and Icy Hot(TM) in dollar sales at drugstores in 2005 within 15 months of its national launch in Canada, validates O24 as a product that works for pain relief and a brand with tremendous growth potential. Swiss Medica plans to continue to build O24's market share via public relations and product sampling to both the medical community and consumers. I would like to thank the Canadian consumers who have tried O24 Pain Neutralizer and recommended it to their friends and family, in addition to the Swiss Medica team and our valued retail partners."
O24 Pain Neutralizer is now available at over 21,000 retail outlets in North America, compared to under 2,000 retail outlets at the beginning of 2005.
Ben-Gay is a registered trademark of Pfizer Corporation. Tiger Balm is a registered trademark of Haw Par Healthcare Ltd. Icy Hot is a trademark of Chattem, Inc.
Wow... very cool... I haven't seen that web site before... thanks chances! You da man!
I think so... I can't get a page either eom
Swiss Medica's O24 Pain Neutralizer Is One Of Canada's Top Selling Topical Pain Relief Products
Business Wire - January 18, 2006 08:00
TORONTO, Jan 18, 2006 (BUSINESS WIRE) -- Swiss Medica, Inc. (OTCBB:SWME) is pleased to announce that according to sales rankings for the latest 52-week period ending November 30, 2005 by ACNielsen, the 30ml spray bottle of O24 Pain Neutralizer was ranked the fourth best selling product in the topical analgesic pain relief category in Canadian drug stores, based on dollar sales at the retail level. O24 Pain Neutralizer was nationally launched in Canadian drug stores in September 2004.
Swiss Medica's Vice President Canadian Sales, Anne Dundon commented "O24 Pain Neutralizer has continued to prove itself in the retail marketplace in Canada. The product is gaining strong acceptance from consumers suffering from muscle aches and pains - plain and simple, this patented all-natural product works."
Swiss Medica's President and COO, Grant Johnson noted "We are extremely pleased with the quick acceptance this product has gained in Canada from consumers, retailers and the medical community within 15 months of national distribution. Our Canadian business recorded just under C$2.0 million in net revenues for 2005 (approximately US$1.7 million) and we expect continued high growth in 2006 as we launch O24 Fibromyalgia and PMS Escape into the Canadian marketplace. In addition, the success of O24 Pain Neutralizer is an excellent indicator of the potential for O24 in the United States as Canada's population is approximately 10 percent the size of that of the United States."
About Swiss Medica, Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com ,www.O24zone.com and www.pmsescape.com.
Swiss Medica's flagship product, the O24 Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24 pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.
Swiss Medica has recently launching the patented O24 Fibromyalgia pain reliever (US Patent #6,444,238B1) over-the-counter in North American retailers. The National Fibromyalgia Association (NFA) recently awarded O24 Fibromyalgia their first NFA Seal of Approval. Upwards of 11 million Americans suffer from the long-term pain associated with Fibromyalgia. In a randomized double blind clinical trial, more than 90 per cent of the patients who used O24 Fibromyalgia reported mild to markedly better improvement, versus only 7 per cent who used the placebo. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest retailer.
Swiss Medica also manufactures PMS Escape(R) which holds US Patent #'s 5760014 and 5612320. PMS Escape(R) is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: www.pmsescape.com for additional information and ordering details.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and purchases and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
Swiss Medica, Inc. (OTC Bulletin Board:SWME)
SOURCE: Swiss Medica, Inc.
Swiss Medica, Inc.
Investor Relations Contact: David Jones
(866) 485-4243
djones@swissmedica.com
OR
Fusion Communications
Media Contact: Dean Mailey
(604) 218-6767
dean@fusioncom.ca
Swiss Medica Announces Fourth Quarter Net Revenues Of US$2.136 Million And Announces Conference Call
Business Wire - January 17, 2006 08:00
TORONTO, Jan 17, 2006 (BUSINESS WIRE) -- Swiss Medica, Inc. (OTCBB:SWME) is pleased to announce fourth quarter net revenues, fiscal year 2005 revenues and operating highlights.
- Net revenues for the fourth quarter ending December 31, 2005 were US$2.136 million - an increase of 21% over third quarter 2005 revenues. This represents the 5th consecutive quarter of revenue growth.
- Net revenues for 2005 grew to US$6.42 million - an increase of 924% over fiscal year 2004.
- O24 Pain Neutralizer is now available in over 21,000 retail outlets in both the USA and Canada, including Walgreens, CVS Pharmacy, Rite Aid, Shoppers' Drug Mart, Wal-Mart Canada and Loblaws.
- Swiss Medica also launched O24 Fibromyalgia and PMS Escape into national retailers in the USA.
Other achievements include:
1. Swiss Medica and O24 Pain Neutralizer received the "Company of the Year" and "Product of the Year" awards from the Northern California Arthritis Foundation.
2. O24 Fibromyalgia became the first clinically tested product specifically for Fibromyalgia to be available in drug stores in the USA, including Rite Aid, Sav-On Drugs and Longs Drugs. O24 Fibromyalgia has received the first and only Seal of Approval from the National Fibromyalgia Association in California. O24 Fibromyalgia will be available in over 15,000 retail outlets in USA by the end of the first quarter of 2006.
3. O24 Fibromyalgia underwent a double blind clinical study at a hospital affiliated with the University of Toronto with outstanding results. Over 90% of participants who used O24 had a reduction in pain versus only 7% who used the placebo.
4. PMS Escape, the only clinically proven OTC product to help ease mood and appetite symptoms of pre-menstrual syndrome is now available at CVS Pharmacy. PMS Escape was developed by renowned MIT (Massachusetts Institute of Technology) academics, and completed successful double blind studies at MIT, Harvard and University of Pennsylvania with excellent results.
5. O24 samples and product information are being distributed by thousands of physicians and other medical professionals to their patients in Canada and USA.
Swiss Medica's management will host a conference call on Wednesday January 25th, 2006 at 4:00 pm EST to discuss the Company's fourth quarter highlights and go forward strategy. Callers from the Toronto area are invited to dial 416-695-9753 at that time to participate. All other callers are invited to dial 1-877-888-4605 to participate. The conference will also be webcast with a direct link from www.swissmedica.com.
Swiss Medica CEO, Raghu Kilambi commented "We are pleased with Swiss Medica's growth in 2005 and are confident that 2006 will be a watershed year for the company and its products as we capitalize on the branding achievements of 2005, and expand distribution of our products into new geographical markets and other channels."
Full fourth quarter and fiscal 2005 audited financial statements will be included in the Company's 10-K, which will be filed with the U.S. Securities and Exchange Commission by March 31, 2006.
About Swiss Medica, Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com.
Swiss Medica's flagship product, the O24 Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24 pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals and athletes in the United States, Canada and in Europe. O24 is widely available throughout the United States and Canada in leading pharmacies and other retailers. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.
Swiss Medica has recently launching the patented O24 Fibromyalgia pain reliever (US Patent #6,444,238B1) over-the-counter in North American retailers. The National Fibromyalgia Association (NFA) recently awarded O24 Fibromyalgia their first NFA Seal of Approval. Upwards of 11 million Americans suffer from the long-term pain associated with Fibromyalgia. In a randomized double blind clinical trial, more than 90 per cent of the patients who used O24 Fibromyalgia reported mild to markedly better improvement, versus only 7 per cent who used the placebo. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest retailer.
Swiss Medica also manufactures PMS Escape(R) which holds US Patent #'s 5760014 and 5612320. PMS Escape(R) is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit: www.pmsescape.com for additional information and ordering details.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and purchases and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
Swiss Medica, Inc. (OTC Bulletin Board:SWME)
SOURCE: Swiss Medica, Inc.
Swiss Medica, Inc.
Investor Relations Contact:
David Jones
(866) 485-4243
djones@swissmedica.com
OR
Fusion Communications
Media Contact:
Dean Mailey
(604) 218-6767
dean@fusioncom.ca
Web Site for German Subsidiary online... looks good! Europe here we come!
www.swissmedica.de
Let's hope so chances... it's time for results now... nothing else will suffice...
If they don't have the numbers Monday they should issue a PR saying why they're not ready and when they will be out... they need to regain credibility with investors and a big delay in the numbers with no explanation is not the way to do that...
chances... yea... either that or early tomorrow around 7am or so... they've done that a few times... nice to see our Swammy picking up!
I kindly request again... please post a link to back up this assertion... if you can not do that then one must assume that post was a lie... if that post is a lie, how can anyone trust any, or all, of your posts... I'll be anxiously awaiting the link...
I appreciate that you're a trader and you'll change your mind to suit your trades... however, that does not mean everyone is that way and I kindly request you respect people on this board who have other styles such as buy and hold...
Oris54 Quote
"1 up day aaand
a couple of posters think it's back up to the moon? Silly"
oris54... we welcome intelligent debate from all sides assuming it's based on fact... please show the post you are referring to where someone mentions "to the moon" for SWME... you cannot as there was no such post... we do not appreciate someone attempting to start an arguement based on lies and that is not the purpose of this board... if you want that type of environment you should go to yahoo boards... best of luck to you...
nice day chances... hopefully we build on it tomorrow... normally a long candle like todays signals the reversal and more follow... let's hope
no idea chances... I haven't been to the PMS Escape web site it awhile but it was in need of a refresh last time I looked...
I have no idea chances... I am totally amazed... I guess some of the recent missteps have made investors cautious... also, I've noticed lots of OTC stocks are getting beat up so it's not isolated to SWME...
I hope so chances but I must admit it's hard to be optimistic anymore... I guess we'll know soon enough... interesting day today BTW, don't know what to make of it...
I hear ya chances... I'm getting a little discouraged here... hopefully the Q4 numbers were very good...
I think we're in 25k stores now although it was not announced as a total store count... what's the point anyway... everytime they announced more stores we just traded down anyway...
Best wishes to all for a healthy, happy, and prosperous 2006! eom
Good deal chances... what's your thoughts on how the product has been selling in retail outlets? Have you been getting any feedback? Best wishes for a prosperous New Year!